Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 24A1 (CYP24A1) is a mitochondrial enzyme that functions as a monooxygenase, primarily involved in the metabolism of vitamin D. It catalyzes the breakdown of active vitamin D (calcitriol) and stored vitamin D (calcidiol) into inactive metabolites, thereby regulating calcium and phosphate balance. Mutations in CYP24A1 can lead to hypercalcemia syndromes. Genetic variants are linked with altered cancer risk.
Not applicable - CYP24A1 is an enzyme that degrades vitamin D, not a drug target itself, but drugs could theoretically target it to modulate Vitamin D levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 24 subfamily A member 1.